-
1
-
-
0038061596
-
Formulation of intravenous Carbamazepine emulsions by SolEmuls technology
-
Akkar A, Müller RH. Formulation of intravenous Carbamazepine emulsions by SolEmuls technology. Eur J Pharm Biopharm 2003;55:305-12.
-
(2003)
Eur J Pharm Biopharm
, vol.55
, pp. 305-312
-
-
Akkar, A.1
Müller, R.H.2
-
2
-
-
0038692100
-
Intravenous itraconazole emulsions produced by SolEmuls technology
-
Akkar A, Müller RH. Intravenous itraconazole emulsions produced by SolEmuls technology. Eur J Pharm Biopharm 2003;56:29-36.
-
(2003)
Eur J Pharm Biopharm
, vol.56
, pp. 29-36
-
-
Akkar, A.1
Müller, R.H.2
-
4
-
-
0035478436
-
In vitro assessment of oral lipid based formulation
-
Porter CJH, Charman WN. In vitro assessment of oral lipid based formulation. Adv Drug Deliver Rev 2001;50:S127-47.
-
(2001)
Adv Drug Deliver Rev
, vol.50
-
-
Porter, C.J.H.1
Charman, W.N.2
-
5
-
-
0036159895
-
-
Sek L, Porter CJ, Kaukonen AM, Charman WN. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 2002;54:29-41.0
-
Sek L, Porter CJ, Kaukonen AM, Charman WN. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 2002;54:29-41.0
-
-
-
-
6
-
-
33744973517
-
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
-
Müller RH, Runge SH, Ravelli V, Mehnert W, Souto EB. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm 2006;317:82-9.
-
(2006)
Int J Pharm
, vol.317
, pp. 82-89
-
-
Müller, R.H.1
Runge, S.H.2
Ravelli, V.3
Mehnert, W.4
Souto, E.B.5
-
7
-
-
33645030096
-
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs
-
Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm 2006;312:179-86.
-
(2006)
Int J Pharm
, vol.312
, pp. 179-186
-
-
Kocbek, P.1
Baumgartner, S.2
Kristl, J.3
-
8
-
-
3843097202
-
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
-
Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004;58:265-78.
-
(2004)
Eur J Pharm Biopharm
, vol.58
, pp. 265-278
-
-
Lindenberg, M.1
Kopp, S.2
Dressman, J.B.3
-
9
-
-
24644495623
-
The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen
-
Lance RS, William JI, Tim JG, Barbara RC. The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen. Drug Dev Ind Pharm 2005;31:515-25.
-
(2005)
Drug Dev Ind Pharm
, vol.31
, pp. 515-525
-
-
Lance, R.S.1
William, J.I.2
Tim, J.G.3
Barbara, R.C.4
-
10
-
-
0035465206
-
Investigations on the occlusive properties of solid lipid nanoparticles (SLN)
-
Wissing S, Lippacher A, Muller R. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosm Sci 2001;52:313-24.
-
(2001)
J Cosm Sci
, vol.52
, pp. 313-324
-
-
Wissing, S.1
Lippacher, A.2
Muller, R.3
-
11
-
-
0345390953
-
Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase
-
Freitas C, Müller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999;47:125-32.
-
(1999)
Eur J Pharm Biopharm
, vol.47
, pp. 125-132
-
-
Freitas, C.1
Müller, R.H.2
|